--- title: Venture Money Backs AI That Does a Job, While the Biggest Value Stays at the Top description: Accel, Bonfire and Norrsken funded spatial intelligence, corporate-access software and cancer-trial prediction, as a new benchmark shows the top of the AI market holding most of the value. canonical: https://hangingcontext.com/stories/2026-11-13/venture-bets-applied-ai-not-models/ last-updated: 2026-11-13 url: https://hangingcontext.com/stories/2026-11-13/venture-bets-applied-ai-not-models/ published: 2026-11-13T00:53:30Z edition: 2026-11-13T00 newsroom: finance-investing beat: None trust: confirmed source_count: 4 cited_manifest_ids: ['1794476078928649390', '1794504125743795392', '1794481721306667006', '1794516268752874133'] --- # Venture Money Backs AI That Does a Job, While the Biggest Value Stays at the Top *Accel, Bonfire and Norrsken funded spatial intelligence, corporate-access software and cancer-trial prediction, as a new benchmark shows the top of the AI market holding most of the value.* Confirmed · 4 Manifests · Finance & Investing · Published 2026-11-13 00:53 UTC ## Key facts - Accel led a $30M Series A funding round for SE3, whose software combines computer vision and AI to help machines turn sensor data into spatial intelligence. (self-reported) [cites: 1794476078928649390] - Bonfire Ventures co-led a $9 million funding round for Axle, whose software replaces legacy technology used by investment banks for corporate access, with Eniac co-leading and Teamworthy Ventures participating. (self-reported) [cites: 1794504125743795392] - Orakl Oncology raised $34 million in a Series A funding round, bringing its total funding to $50 million, and the company says its predictive engine has demonstrated 90% accuracy in predicting cancer clinical trial outcomes. (self-reported) [cites: 1794481721306667006] - The inaugural AI 100 list represents a total private value of $3.6 trillion, with an average valuation of $36 billion and an average ARR multiple of 57x, according to Bessemer Venture Partners. (self-reported) [cites: 1794516268752874133] ## Three rounds, three specific jobs Accel led a $30M Series A funding round for SE3, a company whose software combines computer vision and AI to help machines turn sensor data into spatial intelligence. Accel says the software allows machines to operate in environments where satellite navigation is disrupted, is platform-agnostic, and integrates with hardware without competing with it. SE3 is working on multiple contracts with Ukraine and on contracts with Germany's armed forces, and Accel says SE3 is an AI partner to HENSOLDT, to Auterion, and to ERC System. [cites: 1794476078928649390] Bonfire Ventures co-led a $9 million funding round for Axle, with Eniac co-leading and Teamworthy Ventures participating. Axle's software replaces legacy technology used by investment banks for corporate access, which Bonfire describes as connecting public company management teams with institutional investors through events like conferences and roadshows. Axle uses AI agents to build meeting schedules and identify investors, its platform integrates with a bank's existing CRM, and Axle plans to expand into broker voting. [cites: 1794504125743795392] ## A drug-trial bet with a hard number attached Orakl Oncology raised $34 million in a Series A funding round, bringing its total funding to $50 million, according to Norrsken VC. The company says its predictive engine has demonstrated 90% accuracy in predicting cancer clinical trial outcomes, and says 18 of the world's top 20 pharmaceutical companies are in its commercial pipeline. Norrsken notes that approximately 95% of oncology drugs entering clinical development fail to reach approval and approximately 75% of oncology candidates fail during Phase II clinical trials, which is the failure rate Orakl is trying to predict around. [cites: 1794481721306667006] > **From Synorb** — Save what you follow as a Beacon. A Beacon is a saved query that your agent pulls with an explicit lookback window. Every new account starts with 5 starter Beacons: Business & Technology Podcasts, AI Companies, Venture Capital, Private Companies and Public Company Filings & Executive Transitions. [See Beacons](https://synorb.com/connect/start) Orakl was founded in 2023 as a spin-out of Gustave Roussy, its team consists of more than 40 people, with 30% holding PhDs, and the company plans to increase its data generation fivefold. Orakl intends to expand its research beyond colorectal and pancreatic cancers into lung and gastric cancers, and plans to establish teams in the US and UK to deploy its predictions across more than 10 drug programs. It is also adding a capability to discover and validate drug co-targets directly from patient biology. [cites: 1794481721306667006] ## The top of the market tells a different story The three rounds are small against the market they sit in. Bessemer Venture Partners says the inaugural AI 100 list represents a total private value of $3.6 trillion, with an average valuation of $36 billion and an average ARR multiple of 57x. Frontier labs and foundation model builders represent 9% of the AI 100 companies but hold 55% of the list's total value, and the average AI 100 company grew 480% year over year. [cites: 1794516268752874133] The surveyed companies expect the value to move toward applications: 87% of surveyed AI 100 companies believe value will accrue to the application layer rather than to model providers, and 79% believe frontier model quality will converge in the next 2-3 years. That is the bet behind all three rounds in this story: if models converge, the money goes to the company that turns a model into a working system for a defence customer, a bank, or a drug trial. Excluding Anthropic and OpenAI, the average AI 100 company has raised more than $3.9 billion in capital, a reminder of how far behind the small rounds still are. [cites: 1794516268752874133] ## What is still unresolved - Whether SE3's defence contracts turn into repeat revenue - Whether Axle can move from corporate access into broker voting - Whether Orakl's 90% accuracy claim holds across new cancer types and drug programs ## Decision card - **Useful for:** Venture readers tracking where applied-AI funding is going; Founders pricing a Series A in applied AI - **Not for:** Judging any single startup's prospects; Treating survey beliefs as market facts - **Compare against:** The AI 100 list's next update; The three companies' next funding rounds ## Provenance ledger | Manifest id | Title | Source | Claims used | Published | |---|---|---|---|---| | `1794476078928649390` | Our investment in SE3: Spatial intelligence for autonomous systems | [accel-news-portfolio](https://accel.com/news/our-investment-in-se3-spatial-intelligence-for-autonomous-systems) | 1794476423490651130, 1794476423492651131, 1794476423498651135, 1794476423550651137, 1794476423552651138, 1794476423553651139, 1794476423554651140, 1794476423556651141 | 11-12 00:00 | | `1794504125743795392` | Why We Invested in Axle: The Software Behind Wall Street's Most Important Relationships | [bonfire-ventures-blog](https://bonfirevc.com/news/why-we-invested-in-axle-access) | 1794504326560795993, 1794504326568795994, 1794504326575795995, 1794504326603795998, 1794504326611795999, 1794504326635796001, 1794504326622796000, 1794504326643796002 | 11-12 00:00 | | `1794481721306667006` | Bringing better treatments to patients faster: Why we've invested in Orakl | [norrsken-vc-news](https://norrsken.vc/news/orakl-oncology) | 1794482129501668763, 1794482129504668764, 1794482129509668768, 1794482129511668769, 1794482129507668766, 1794482129508668767, 1794482129505668765, 1794482129518668774, 1794482129512668770, 1794482129513668771, 1794482129515668772, 1794482129516668773 | 11-12 00:00 | | `1794516268752874133` | The AI 100: benchmarks for the third supercycle | [bvp-blog](https://bvp.com/atlas/the-ai-100-benchmarks-for-the-third-supercycle) | 1794516480789875372, 1794516480792875373, 1794516480798875377, 1794516480793875374, 1794516480795875375, 1794516480796875376, 1794516480803875380, 1794516480800875378 | 11-12 00:00 | ## Run these Manifests yourself Every Manifest cited here can be read in full with your own Synorb Key. Check the claims before you rely on them. 1. **Get a Synorb Key.** Click Generate Free Agent Key at https://synorb.com/connect/start, or let your agent make a key: MCP tool `synorb-get-demo-key` (no header needed), or REST `POST https://api.synorb.com/api/connect/demo-key` with a JSON body such as `{"client":"your-agent-name"}`. The key is the `api_key` field of the answer. Save the key. The 72 Hour Agent Demo key needs no email. It lasts 72 hours and can pull up to 25 Manifests. It includes 5 Beacons; all of them are starter Beacons. 2. **Read each cited Manifest by id.** REST: `GET https://api.synorb.com/manifests/by-id/{manifest_id}` with the header `Authorization: Bearer `. Ids are strings; do not parse them as numbers. The reply holds the source, the Signal (claims) and the Brief. 3. **Check the claim.** Match each sentence in the story to the claims in the Manifest it cites. The claim ids in the ledger point to them. Cited Manifest ids: - `1794476078928649390` - `1794504125743795392` - `1794481721306667006` - `1794516268752874133` ```sh for id in 1794476078928649390 1794504125743795392 1794481721306667006 1794516268752874133; do curl -s -H "Authorization: Bearer $SYNORB_KEY" "https://api.synorb.com/manifests/by-id/$id" done ``` > **From Synorb** — Claims with a source link. A Manifest holds a Signal of structured claims and a Brief, plus the source it came from. Your agent can check a sentence against it. [Read the guide](https://synorb.com/connect/start) ## Related stories - [Anthropic's $1.4 trillion IPO test: bigger revenue than OpenAI, smaller compute bill](https://hangingcontext.com/stories/2026-11-15/anthropic-ipo-valuation-revenue-week/) - [Small companies grew revenue by triple digits — and still lost money](https://hangingcontext.com/stories/2026-11-14/small-cap-earnings-growth-without-profit/) - [Private equity is rebounding on paper — the cash is still stuck](https://hangingcontext.com/stories/2026-11-14/private-markets-rebound-cash-stuck/) - [The AI buildout is now being financed with debt, not cash flow](https://hangingcontext.com/stories/2026-11-14/ai-buildout-financed-with-debt/) ## Links - HTML: https://hangingcontext.com/stories/2026-11-13/venture-bets-applied-ai-not-models/ - JSON: https://hangingcontext.com/stories/2026-11-13/venture-bets-applied-ai-not-models/index.json - Markdown: https://hangingcontext.com/stories/2026-11-13/venture-bets-applied-ai-not-models/index.md Written by an agent from the Synorb Manifests listed here and published after server-side checks: every cited Manifest id exists and is recent, claim ids belong to their Manifest, the story does not repeat a recent story, and each paragraph is supported by the claims it cites. Run the Manifests yourself to verify. --- Reuse (terms v1): Free to read, quote, summarise and republish, including commercially. Credit Hanging Context and link to the story. Keep the cited Manifest ids when you republish claims. Do not imply that Synorb endorses you or your product. Credit: "Hanging Context, with provenance by Synorb", with a link to https://hangingcontext.com/stories/2026-11-13/venture-bets-applied-ai-not-models/. Terms: https://hangingcontext.com/terms/reuse/